A. A. Kuular

A. A. Kuular

Auto-generated profile, based on publicly available information

A. A. Kuular

Almazov National Medical Research Centre

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ELE. A. Lyasnikova
E. A. Lyasnikova
AKA. A. Kuular
A. A. Kuular
APA. V. Pavlovskaya
A. V. Pavlovskaya
AVA. N. Vlasenko
A. N. Vlasenko
AKA. V. Kozlenok
A. V. Kozlenok
ESE. V. Shlyakhto
E. V. Shlyakhto
Aim. To analyze and compare the clinical, echocardiographic characteristics and serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels depending on the central cardiometabolic risk factors, with a focus on obesity, in patients with heart failure (HF) with mid-range ejection fraction (HFmrEF).Material and methods. The study included 111 patients with old myocardial infarction and HFmrEF (men, 100%; mean age, 60 years) predominantly of NYHA class II. Echocardiography and blood sampling for NT-proBNP were performed with sinus rhythm. Left atrial volume (LAV) and left ventricular mass (LVM) were indexed to body surface area (BSA) and height raised to a power.Results. Type 2 diabetes, overweight and obesity were diagnosed in 25%, 19%, 38% of cases, respectively, and were associated with greater changes in the morphologic and functional left ventricular parameters. There were no intergroup differences among patients with and without obesity in the LAV and LVM indexed to BSA. However, in patients with a body mass index (BMI) ≥30 kg/m2, the LAV indexed to height squared and LVM indexed to height2,7 were higher (p40%. This requires the search for optimal standardization and the development of a unified methodological approach.

3 May 2020 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
EEE. I. Emelina
E. I. Emelina
AIA. A. Ibragimova
A. A. Ibragimova
IGI. I. Ganieva
I. I. Ganieva
GGG. E. Gendlin
G. E. Gendlin
INIGOR G. NIKITIN
IGOR G. NIKITIN
MSM. Yu. Sitnikova
M. Yu. Sitnikova
Objective Comparative analysis of structural and functional specific features of the heart in patients with toxic cardiomyopathy (TCMP) with a low left ventricular ejection fraction (LVEF) and severe, chronic heart failure (CHF) and in patients with idiopathic dilated cardiomyopathy (DCMP) and similar LVEF and CHF severity. Materials and Methods This observational, single-site study included 15 patients with TCMP (12 of them received treatment including anthracycline antibiotics and 3 patients received targeted therapies) and 26 patients with idiopathic DCMP. Data of echocardiography were compared for patients with TCMP and DCMP with comparably low LVEF of <40 %. Results In patients with severe heart damage associated with antitumor therapy with low LVEF, volumetric and linear indexes of left and right ventricles and the left atrium (left atrial volume index (LAVI), 33.7 (21.5–36.9) ml / m2; right ventricular end-diastolic dimension (RVDd), 2.49 (1.77–3.53) cm; and end-diastolic volume index (EDVI), 78.0 (58.7–90.0) ml / m2) were considerably less than in the DCMP group (LAVI, 67.1 (51.1–85.0) ml / m2; RVDd, 4.05 (3.6–4.4) cm; and EDVI, 117.85 (100.6–138.5) ml / m2, p<0.0001). Furthermore, LV wall thickness and pulmonary artery systolic pressure did not differ in these groups. Both in men and women with TCMP, LAVI and EDVI were significantly less than in men and women with DCMP. Conclusion The study showed significant differences in parameters of cardiac remodeling. In TCMP patients as distinct from DCMP patients, despite a pronounced decrease in LVEF, LV dilatation was absent or LV volumetric parameters were moderately increased with a more severe somatic status.

22 November 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
Yuriy VakhrushevYuriy Vakhrushev
Yuriy Vakhrushev
AKA. A. Kuular
A. A. Kuular
VLViktoriia Lebedeva
Viktoriia Lebedeva
AKA. A. Kozyreva
A. A. Kozyreva
AKAnna Kostareva
Anna Kostareva
ELE. A. Lyasnikova
E. A. Lyasnikova
Aim. To study the prevalence of RBM20 gene polymorphisms and their relationship with the structural and functional left atrial (LA) characteristics in patients with coronary artery disease and heart failure with reduced ejection fraction (HFrEF).Material and methods. The study included 138 men aged 55,8±6,6 years with prior myocardial infarction ³12 months ago and HFrEF (class II-IV heart failure, left ventricular ejection fraction (Simpson’s methods), 25,1±7,2%). The control group consisted of 384 healthy donors. Genotyping of two RBM20 polymorphic variants (rs942077 and rs35141404) was performed by real-time polymerase chain reaction.Results. The prevalence of RBM20 polymorphisms did not differ in the HFrEF cohort and the control group. The GA rs35141404 genotype was more common among patients with a less pronounced increase in LA volume index (LAVI) (p=0,034). The minor A allele rs35141404 was associated with a protective effect on severe LA remodeling. However, this association did not reach the level of significance.Conclusion. For the rs942077 and rs35141404 polymorphic variants of the RBM20 gene, no significant associations were found with the LA size and atrial fibrillation presence in patients with HFrEF and old myocardial infarction. There was a tendency towards the association of the A allele and the GA rs35141404 genotype with a protective effect on LA remodeling. The data obtained confirm the need for further search for genotype-phenotype relationships of a wider population of patients with heart failure and coronary artery disease.

15 July 2026 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
AKA. A. Kuular
A. A. Kuular
ELE. A. Lyasnikova
E. A. Lyasnikova
LCL. Yu. Cheban
L. Yu. Cheban
MSM. Yu. Sitnikova
M. Yu. Sitnikova
ESE. V. Shlyakhto
E. V. Shlyakhto
ЕШЕ. В. Шляхто
Е. В. Шляхто
Background. The relationship between metabolic risk factors, chronic kidney disease (CKD), metabolic-associated fatty liver disease (MAFLD), and cardiovascular diseases (CVD) is highlighted in the concept of сardiovascular-kidney-liver-metabolic syndrome (CKLMS), which is closely associated with competing risks of adverse outcomes. The impact of the burden of CKLMS remains poorly understood in chronic heart failure (HF) in national cohorts. Objective. To evaluate the frequency of CKLMS components, their combinations, and their impact on the long-term prognosis of patients with HF with mildly reduced ejection fraction (LVEF) (HFmrEF) and post-infarction cardiosclerosis. Design and methods. This was a retrospective analysis of data from a prospective, observational, single-center study involving 160 men (median age 62 years) with post-infarction cardiosclerosis and HFmrEF I (15 %) / II (85 %) NYHA functional class, who had been examined in 2018–2020. All patients received optimal medical therapy for HF and concomitant diseases. Follow-up was conducted through telephone contact / clinic visit at intervals of 6-12 months. The average follow-up period was 5 years (62 [49–64] months). Fatal events were assessed (total mortality, death from CVD and non-cardiovascular causes). Depending on the presence of CKLMS diseases (at the start of observational study), namely: obesity, type 2 diabetes mellitus (T2DM) / impaired glucose tolerance (IGT), CKD, MAFLD patients were divided into phenotypic groups. Results. A high frequency of CKLMS diseases was observed. Arterial hypertension (HTN) and dyslipidemia were detected in 92 % and 100 % of patients, respectively. Obesity/overweight and T2DM/IGT were registered in 43 % / 44 % and 32 % / 3 % of patients, respectively. CKD and MAFLD were diagnosed in every fifth patient. The presence of two or more CKLMS diseases was observed in 33 % of the participants. HTN was registered in 91 % of cases in the absence of the analyzed CKLMS diseases; in 96 % of cases in the presence of one, and in 98 % of cases in the presence of two or more CKLMS diseases. The most common phenotypic group of HFmrEF was represented by a combination of CKD + T2DM/IGT + obesity. The five-year survival rate of patients with HFmrEF was 76 %. The leading causes of death were CVD and cancer. The CKD, LVEF, and N-terminal brain natriuretic propeptide (NT-proBNP) were independent predictors of poor prognosis. The presence of CKD in a patient with HFmrEF was associated with a more than 3-fold increased risk of mortality: OR 3,5; 95 % confidence interval (CI) 1,45–8,40; p = 0,005. The highest five-year mortality was observed in individuals with CKD + T2DM/IGT (obesity in 71 % of cases) and CKD + T2DM/IGT + MAFLD (obesity in 69 % of cases). Conclusions. Patients with HFmrEF and post-infarction cardiosclerosis had a higher frequency of metabolic syndrome components: together with a high occurrence of HTN, at least two CKLMS diseases (obesity, T2DM/IGT, CKD, MAFLD) were detected in every third patient. Phenotypic groups of HFmrEF within CKLMS associated with CKD had the most unfavorable prognosis. The presented data confirm the need for an interdisciplinary approach to the management of patients with HF and the use of a personalized strategy based on pathophysiological phenotypes.

6 March 2026 in Translational Medicine
Verified
Journal Article
Open access
PDF file
LCL. Yu. Cheban
L. Yu. Cheban
ELE. A. Lyasnikova
E. A. Lyasnikova
ALA. A. Loboda
A. A. Loboda
ПСП. С. Сокольникова
П. С. Сокольникова
RSRostislav Skitchenko
Rostislav Skitchenko
ESE. V. Shlyakhto
E. V. Shlyakhto
Myocardial repolarization disturbances resulting in an increased value of dispersion of ventricular repolarization (DR) are associated with the development of life-threatening ventricular arrhythmias. The main tool for detection of repolarization disorders is electrocardiography (ECG).    This review is devoted to the new knowledge regarding the physiological and clinical significance of DR and its ECG-reflection. The search for scientific literature was performed using e-LIBRARY, CyberLeninka and Pubmed data bases and the keywords (dispersion of repolarization, QT interval dispersion, Tpe interval, Tpe interval dispersion, Tpe/QT ratio) in different Russian and English spellings. The analysis of experimental, clinical and in silico studies demonstrated that the interval between the peak and the end of T-wave (Tpe) and its derivatives (relatively new ECG-indices, not yet widely used in clinical practice — Tpe interval dispersion and Tpe/QT ratio) provide information of both global and local dispersion of ventricular repolarization, being the proven useful predictors of life-threatening arrhythmias associated with the increased repolarization heterogeneity and the total mortality, while the dispersion of QT interval (the most “traditional” index of DR) is the least accurate measure of DR and arrhythmic risk. The threshold values of the considered ECG-indices of DR are given, and the age- and sex-dependence of them is discussed. The peculiarities of T-wave parameters measuring as well as the problems and the prospects of searching for the new arrhythmogenic ECG-indices are discussed.